h lundbeck as profit more than triples on u s partners payments danish drug maker h lundbeck ass net profit more than tripled in the second quarter as payments from its u s partner forest laboratories inc recovered from last years slump the copenhagen companys net profit rose to million danish kroner &# million from million kroner a year earlier in lundbecks results were weighed down by an inventory reduction of forest labs which sells lundbecks blockbuster antidepressant lexapro in the u s sales increased to billion kroner from billion kroner pressure on lundbeck to find acquisitions or merge with a larger company has increased this year after the company failed in two late stage clinical trials and had to postpone the rollout of a u s sales force the patent of lexapro and its european sister drug cipralex will expire in in the u s and in europe the company has yet to find a replacement drug 
